Influence of curcumin-loaded cationic liposome on anticancer activity for cervical cancer therapy

Colloids and Surfaces B: Biointerfaces

Volumn 114, Issue , 2014, Pages 349-356

  Saengkrit, Nattika ^a   Saesoo, Somsak ^a   Srinuanchai, Wanwisa ^a   Phunpee, Sarunya ^a   Ruktanonchai, Uracha Rungsardthong ^a  

^a NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

Cervical cancer; Cholesterol; Curcumin; Liposomes; Surfactant

Indexed keywords

CELL CULTURE; CELL DEATH; CHOLESTEROL; SURFACE ACTIVE AGENTS;

ANTICANCER ACTIVITIES; CATIONIC LIPOSOMES; CELLULAR RESPONSE; CERVICAL CANCERS; CURCUMIN; DELIVERY VEHICLE; LIPOSOMAL NANOPARTICLES; THREE COMPONENT;

LIPOSOMES;

CHOLESTEROL; CURCUMIN; DIDECYLDIMETHYLAMMONIUM BROMIDE; LIPOSOME; NONIONIC SURFACTANT; QUATERNARY AMMONIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER THERAPY; CELL DEATH; CELL INTERACTION; CELL LINE; CELL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENCAPSULATION; HELA CELL; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; SIHA CELL; UTERINE CERVIX CANCER;

CERVICAL CANCER; CHOLESTEROL; CURCUMIN; LIPOSOMES; SURFACTANT;

ANTINEOPLASTIC AGENTS; CATIONS; CELL DEATH; CELL LINE, TUMOR; CELL SHAPE; CELL SURVIVAL; CURCUMIN; ENDOCYTOSIS; FEMALE; HUMANS; LIPOSOMES; MICROSCOPY, ATOMIC FORCE; PARTICLE SIZE; STATIC ELECTRICITY; UTERINE CERVICAL NEOPLASMS;

EID: 84890999585     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.10.005     Document Type: Article

References (41)

1. Kohli K., Ali J., Ansari M.J., Raheman Z. Indian J. Pharmacol. 2005, 3:141.
2. AdMenon V.P., Sudheer A.R. Exp. Med. Biol. 2007, 595:105.
3. Bae M.K., Kim S.H., Jeong J.W., Lee Y.M., Kim H.S., Kim S.R., Yun I., Bae S.K., Kim K.W. Oncol. Rep. 2006, 15:1557.
4. Anand P., Sundaram C., Jhurani S., Ajaikumar B., Kunnumakkara B.B. Cancer Lett. 2008, 267:133.
5. Johnson J.J., Mukhtar H. Cancer Lett. 2007, 255:170.
6. Ravindran J., Prasad S., Aggarwal B.B. AAPS 2008, 3:495.
7. Hatcher H., Planalp R., Cho J., Torti F.M., Torti S.V. Cell. Mol. Life Sci. 2008, 11:1631.
8. Aggarwal B.B. Adv. Exp. Med. Biol. 2007, 595:75.
9. Goel A., Kunnumakkara A.B., Aggarwal B.B. Biochem. Pharmacol. 2008, 75:787.
10. Yallapu M.M., Maher D.M., Sundram V., Bell M.C., Jaggi M., Chauhan S.C. J. Ovarian Res. 2010, 3:11.
11. Yallapu M.M., Jaggi M., Chauhan S.C. Drug Discov. Today 2012, 17:1/2.
12. Yallapu M.M., Othman S.F., Curtis E.T., Gupta B.K., Jaggi M., Chauhan S.C. Biomaterials 2011, 32:1890.
13. De Souza F.F., Dos Santos M.C., Dos Passos D.C.S., De Lima E.C.O., Guillo L.A. J. Nanosci. Nanotechnol. 2011, 11:7603.
14. Bigelow N.W. J. Am. Oil Chem. 2011, 1:572.
15. Fewell J.G., Matar M., Slobodkin G., Han S.O., Rice J., Hovanes B. J. Control. Release 2005, 109:288.
16. Campbell R.B., Ying B., Kuesters G.M., Hemphill H. J. Pharm. Sci. 2009, 98:411.
17. Schulze M., Teifel U., Michaelis K., Naujoks M., Dellian Int. J. Cancer 2003, 5:561.
18. Schmitt-Sody M., Strieth S., Krasnici S., Sauer B., Schulze B., Teifel M., Michaelis U., Naujoks K., Dellian M. Clin. Cancer Res. 2003, 9:2335.
19. Strieth S., Nussbaum C.F., Eichhorn M.E., Fuhrmann M., Teifel M., Michaelis U., Berghaus A., Dellian M. Int. J. Cancer 2008, 122:452.
20. Lin Y.L., Liu Y.K., Tsai N.M., Hsieh J.H., Chen C.H., Lin C.M., Lin C.M., Liao K.W. Nanomedicine 2012, 3:318.
21. Saesoo S., Sramala I., Soottitantawat A., Charinpanitkul T., Rungsardthong U. J. Microencapsul. 2010, 27:436.
22. Bangham A.D., Standish M.M., Watkins J.C. J. Mol. Biol. 1965, 13:238.
23. Ahn T. Macromol. Res. 2009, 17:956.
24. Hategan A., Law R., Kahn S., Discher D.E. Biophys. J. 2003, 85:2746.
25. Karewicz A., Dorota B., Gzyl-Malcher B., Kepczynski M., Lach R., Nowakowska M. Colloids Surf. B 2011, 88:231.
26. Marcelino J., Lima J.L., Reis S., Matos C. Chem. Phys. Lipids 2007, 146:94.
27. Vanniasinghe A.S., Bender V., Manolios N. J. Semin. Arthritis 2009, 39:182.
28. Arakawa T., Prestrelski S.J., Kenney W.C., Carpenter J.F. Adv. Drug. Deliv. Rev. 2001, 46:307.
29. Pesch M., Richter K., Frings S., Uhrig J.F. Nat. Methods 2006, 3:597.
30. Nagarsenker M.S., Londhe V.Y. Int. J. Pharm. 2003, 25:49.
31. Jiao X., ichard R., Wang Y.H., Feng Z., Alter H.J., Wai-Kuo Shih J. Hepatology 2003, 37:452.
32. Wang B., Zhang S., Cui S., Yang B., Zhao Y., Chen H., Hao X., Shen Q. J. Biotechnol. Lett. 2012, 34:19.
33. Chien J., Wang D., Carbonaro S., Lei B., Miller S., Sheikh S.M., Ali M.U., Ahmad I. Cancer Gene Ther. 2005, 12:321.
34. Shahani K., Suresh Kumar S., Diana F., Angela B., Linan M., Jayanth P. Cancer Res. 2010, 70(June):4443.
35. Lappalainen K., Jaaskelainen I., Syrjanen K., Urtti A., Syrjanen S. Pharm. Res. 1994, 11:1127.
36. Kusumoto K., Tomoyuki I. J. Control. Release 2010, 147:246.
37. Yallapu M.M., Jaggi M., Chauhan S.C. Colloids Surf. B 2010, 79:113.
38. Kim K.S., Cho C.H., Park E.K., Jung M.H., Yoon K.S., Park H.K. PLOS ONE 2012, 7:e30066.
39. Kunnumakkara A.B. Cancer Lett. 2008, 269:199.
40. Murali M., Yallapu M.M., MeenaJaggi C., Subhash C., Chauhan C. Drug Discov. Today 2012, 17:71.
41. Kim K.C., Choo C.H., Park E.K., Jung M.H., Yoon K.S. Biophys. J. 2012, 73:1205.